Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals

References

• Beaumier, P. L., Hwang, K. J., Slattery, J. T. (1983). Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from the circulation. Res Commun Chem Pathol Pharmacol 39:277–289.
   PubMedGoogle Scholar
• Blume, G., Cevc, G. (1993). Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta 1146:157–168.
   PubMed Web of Science ®Google Scholar
• Elbayoumi, T. A., Torchilin, V. P. (2006). Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies. Eur J Nucl Med Mol Imaging 33:1196–1205.
   PubMed Web of Science ®Google Scholar
• Fritzberg, A. R. (1987). Advances in 99mTc-labeling of antibodies. Nuklearmedizin 26:7–12.
   PubMedGoogle Scholar
• Gabizon, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., et al. (1994). Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polethylene-glycol–coated liposomes. Cancer Res 54:987–992.
   PubMed Web of Science ®Google Scholar
• Goyal, P., Goyal, K., Kumar, S. G. V., Singh, A., Katare, O. P., Mishra, D. N. (2005). Liposomal drug delivery systems—clinical applications. Acta Pharm 55:1–25.
   PubMedGoogle Scholar
• Harivardhan Reddy, L., Sharma, R. K., Chuttani, K., Mishra, A. K., Murthy, R. S. (2005). Influence of administration route on tumor uptake and biodistribution of etoposide-loaded solid lipid nanoparticles in Dalton’s lymphoma tumor-bearing mice. J Contr Rel 105:185–198.
   PubMed Web of Science ®Google Scholar
• Immordino, M. L., Dosio, F., Cattel, L. (2006). Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 1:297–315.
   PubMed Web of Science ®Google Scholar
• Ishfaq, M. M., Hussain, N., Jehangir, M. (2006). DOTA-Tyr3-octreotate: labeling with β-emitting radionuclides for the preparation of potential therapeutic radiopharmaceuticals. J Radioanal Nucl Chem 273:689–694.
   Web of Science ®Google Scholar
• Lasic, D. D., Papahadjopoulos, D. (1995). Liposomes revisited. Science 267:1275–1276.
   PubMed Web of Science ®Google Scholar
• Laverman, P., Boerman, O. C., Oyen, W. J., Dams, E. T., Storm, G., Corstens, F. H. (1999a). Liposomes for scintigraphic detection of infection and inflammation. Adv Drug Deliv Rev 37:225–235.
   PubMed Web of Science ®Google Scholar
• Laverman, P., Dams, E. T., Oyen, W. J., Storm, G., Koenders, E. B., Prevost, R., et al. (1999b). A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. J Nucl Med 40:192–197.
   PubMed Web of Science ®Google Scholar
• Li, L., Wartchow, C. A., Danthi, S. N., Shen, Z., Dechene, N., Pease, J., et al. (2004). A novel antiangiogenesis therapy using an integrin antagonist or anti-FLK-1 antibody-coated 90Y-labeled nanoparticles. Int J Radiat Oncol Biol Phys 58:1215–1227.
   PubMed Web of Science ®Google Scholar
• Lian, T., Ho, R. J. (2001). Trends and developments in liposome drug delivery systems. J Pharm Sci 90:667–680.
   PubMed Web of Science ®Google Scholar
• Mahmood, A., Jones, J. G. (2003). Technetium radiopharmaceuticals. In: Welch, M., Redvanly, C. S. (Eds.), Handbook of radiopharmaceuticals (pp 323–363). West Sussex, UK: John Wiley & Sons, Ltd.
   Google Scholar
• McAfee, J. G., Thakur, M. L. (1976). Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. I. Soluble agents. J Nucl Med 17:480–487.
   PubMed Web of Science ®Google Scholar
• Meares, C. F., Moi, M. K., Diril, H., Kukis, D. L., McCall, M. J., Deshpande, S. V., et al. (1990). Macrocyclic chelates of radiometals for diagnosis and therapy. Br J Cancer Suppl 10:21–26.
   PubMedGoogle Scholar
• Richardson, V. J., Jeyasingh, K., Jewkes, R. F., Ryman, B. E., Tattersall, M. H. N. (1978). Possible tumor localization of Tc-99m-labeled liposomes: effects of lipid composition, charge, and liposome size. J Nucl Med 19:1049–1054.
   PubMed Web of Science ®Google Scholar
• Rofsky, N. M., Lee, V. S., Laub, G., Pollack, M. A., Krinsky, G. A., Thomasson, D., et al. (1999). Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212:876–884.
   PubMed Web of Science ®Google Scholar
• Rolland, A., Collet, B., Le Verge, R., Toujas, L. (1989). Blood clearance and organ distribution of intravenously administered polymethacrylic nanoparticles in mice. J Pharm Sci 78:481–484.
   PubMed Web of Science ®Google Scholar
• Scherphof, G. L. (1985). Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupffer cells in vivo and in vitro. Ann N Y Acad Sci 446:368–384.
   PubMed Web of Science ®Google Scholar
• Stark, B., Debbage, P., Andreae, F., Mosgoeller, W., Prassl, R. (2007). Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery. Biochim Biophys Acta 1768:705–714.
   PubMed Web of Science ®Google Scholar
• Torchilin, V. P. (2006). Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532–1555.
   PubMed Web of Science ®Google Scholar
• Torchilin, V. P., Lukyanov, A. N. (2003). Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today 8:259–266.
   PubMed Web of Science ®Google Scholar
• Torchilin, V. P. (2000). Polymeric contrast agents for medical imaging. Curr Pharm Biotechnol 1:183–215.
   PubMedGoogle Scholar
• Torchlini, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145–160.
   PubMed Web of Science ®Google Scholar
• Waibel, R., Alberto, R., Willuda, J., Finnern, R., Schibli, R., Stichelberger, A., et al. (1999). Stable one-step technetium-99m labelling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol 17:897–901.
   PubMed Web of Science ®Google Scholar
• Weiner, R. E., Thakur, M. (2003). Chemistry of gallium and indium radiopharmaceuticals. In: Welch, M., Redvanly, C. S. (Eds.), Handbook of radiopharmaceuticals (pp 363–399). West Sussex, UK: John Wiley & Sons, Ltd.
   Google Scholar
• Woltering, E., Mamikunian, P. M., Zeitz, S., Krutzik, S. R., Go, V. L. W., Vinik, A. I., et al. (2005). Octreotide acetate (LAR) dose effect on plasma octreotide levels: impact on neuroendocrine tumour management. J Clin Oncol 23:3177.
   Web of Science ®Google Scholar